Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Longitudinal Cohort Study
100%
Cardiometabolic Risk
100%
Metabolic Adaptation
100%
Plasma Lipidomics
100%
Lipidomic Profile
100%
Lipidomic Profiling
100%
Preconception Cohort
100%
Adaptation to Pregnancy
100%
Glycemic Traits
60%
Circulating Lipids
60%
Fasting Plasma Glucose
40%
Glucose Concentration
40%
Fasting Insulin
40%
Physiological Condition
40%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
40%
Insulin Concentration
40%
Lipid Modification
40%
Body Weight Changes
40%
Lipid Signature
40%
Post-load Glucose
40%
Early Intervention
20%
Cardiometabolic Health
20%
Potential Biomarkers
20%
Lipid Metabolism
20%
Health Intervention
20%
Pregnant Women
20%
Plasma Samples
20%
Singapore
20%
Association Study
20%
Glucose-insulin System
20%
Hemoglobin A1c (HbA1c)
20%
Modifiable Risk Factors
20%
Aberrations
20%
Hyperglycemia
20%
Glycated Hemoglobin A1c
20%
Large Sample Size
20%
Metabolic Potential
20%
Phospholipids
20%
Pre-pregnancy BMI
20%
Population-based Study
20%
Sphingomyelin
20%
Presto
20%
Longitudinal Cohort
20%
Longitudinal Change
20%
MS-MS
20%
Lipid Species
20%
Adverse Outcomes
20%
Glucose Tolerance Status
20%
Physiological Demands
20%
Preconception Period
20%
Maternal Outcomes
20%
Impaired Glucose Tolerance
20%
Circulating Concentration
20%
Child Outcomes
20%
Childbearing Women
20%
Pre-pregnancy Body Mass Index
20%
Maternal Plasma
20%
Medicine and Dentistry
Cohort Analysis
100%
Cardiometabolic Risk
100%
Glycemic
75%
Hemoglobin A1c
50%
Body Mass Index
50%
Homeostatic Model Assessment
50%
Physiological State
50%
Glucose Test
50%
Body Weight Change
50%
Biological Marker
25%
Lipid Metabolism
25%
Hyperglycemia
25%
Early Intervention
25%
Impaired Glucose Tolerance
25%
Phospholipid
25%
Sphingomyelin
25%
Glycated Hemoglobin
25%
Maternal Plasma
25%
Adverse Outcome
25%
Tandem Mass Spectrometry
25%
Offspring
25%
Biochemistry, Genetics and Molecular Biology
Cohort Study
100%
Blood Plasma
100%
Lipid
100%
Insulin Resistance
18%
Glucose Test
18%
Glucose Tolerance Test
18%
Body Weight Change
18%
Lipid Metabolism
9%
Hyperglycemia
9%
Impaired Glucose Tolerance
9%
Body Mass
9%
Sample Size
9%
Glucose Blood Level
9%
Glycated Hemoglobin
9%
Tandem Mass Spectrometry
9%
Phospholipid
9%
Sphingomyelin
9%
Offspring
9%
Neuroscience
Blood Plasma
100%
Risk Factor
60%
Hemoglobin A1c
40%
Body Mass Index
40%
Glucose Tolerance Test
40%
Metabolic Pathway
20%
Glycosylated Hemoglobin
20%
Phospholipid
20%
Hyperglycemia
20%
Sphingomyelin
20%